Literature DB >> 3196090

24-hour ambulatory dual gastroduodenal pH monitoring. The role of acid in duodenal ulcer disease.

C A Eriksen1, S A Sadek, A Cuschieri.   

Abstract

A new system for long-term, 24-hour, ambulatory dual gastroduodenal pH monitoring is described. Eighteen patients with active duodenal ulcers and ten healthy subjects were studied. Simultaneous gastric and duodenal bulb pH were measured during fasting, the ingestion of a solid meal, and for the remainder of the 24-hour period. The gastric pH profile was similar for both groups. There was no significant difference between the fasting duodenal bulb pH of the duodenal ulcer (DU) patients and controls. The daytime and nocturnal duodenal acid exposure was similar for both groups. The meal caused a similar pattern of duodenal acidification in both controls and DU patients, and acid neutralization appeared to be effective in DU patients. The role of acid in the duodenal bulb does not appear to be of primary pathophysiologic importance in duodenal ulcer disease.

Entities:  

Mesh:

Year:  1988        PMID: 3196090      PMCID: PMC1493838          DOI: 10.1097/00000658-198812000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  16 in total

1.  Levels of intragastric and intraduodenal acidity.

Authors:  M ATKINSON; K S HENLEY
Journal:  Clin Sci       Date:  1955-02       Impact factor: 6.124

2.  Problems associated with assessment of the effects of diet, antacids, and anticholinergic agents on gastric and duodenal acidity, as measured by the glass electrode in situ.

Authors:  R A ROVELSTAD; F T MAHER
Journal:  Gastroenterology       Date:  1962-05       Impact factor: 22.682

3.  Factors influencing the continuous recording of in situ pH of gastric and duodenal contents.

Authors:  R A ROVELSTAD; C A OWEN; T B MAGATH
Journal:  Gastroenterology       Date:  1952-04       Impact factor: 22.682

4.  The continuous twelve-hour nocturnal gastric secretion in normal individuals and in patients with duodenal ulcer after a 24-hour fast.

Authors:  E LEVIN; J B KIRSNER; W L PALMER
Journal:  Gastroenterology       Date:  1950-07       Impact factor: 22.682

5.  Duodenal bulb pH in normal subjects.

Authors:  S Hannibal; S J Rune
Journal:  Eur J Clin Invest       Date:  1983-12       Impact factor: 4.686

6.  The use of radiotelemetry techniques for the in vivo assessment of antacids.

Authors:  G O'Sullivan; B J Harrison; R E Bullingham
Journal:  Anaesthesia       Date:  1984-10       Impact factor: 6.955

7.  Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists.

Authors:  C J Fimmel; A Etienne; T Cilluffo; C von Ritter; T Gasser; J P Rey; P Caradonna-Moscatelli; F Sabbatini; F Pace; H W Bühler
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

8.  Difference of interdigestive gastroduodenal motility and duodenal pH between duodenal and gastric ulcer patients.

Authors:  T Sekiguchi; T Nishioka; M Kogure; M Kusano; M Sugiyama; H Fukagawa; S Kobayashi
Journal:  Nihon Heikatsukin Gakkai Zasshi       Date:  1985-07

9.  Duodenal pH in health and duodenal ulcer disease: effect of a meal, Coca-Cola, smoking, and cimetidine.

Authors:  R F McCloy; G R Greenberg; J H Baron
Journal:  Gut       Date:  1984-04       Impact factor: 23.059

10.  Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency.

Authors:  L Ovesen; F Bendtsen; U Tage-Jensen; N T Pedersen; B R Gram; S J Rune
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

View more
  3 in total

1.  Duodenal acid clearance in humans: observations made with intraluminal impedance recording.

Authors:  Guillaume Savoye; Jac Oors; André Smout
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

2.  24-hour ambulatory study of duodenal pH.

Authors:  D Kerrigan; N Bird; A Johnson
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

Review 3.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.